Navigation Links
Metabasis Therapeutics Presents Results of Preclinical Studies for,MB07811, Its Novel Product Candidate for the Treatment of,Hyperlipidemia, at the Endocrine Society's Annual Meeting

SAN DIEGO--(BUSINESS WIRE)--Jun 6, 2007 - Metabasis Therapeutics, Inc. (Nasdaq:MBRX), a biopharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of metabolic and liver diseases by applying unique capabilities for targeting the liver and liver pathways, announced today that two posters were presented at the Endocrine Society's 89th Annual Meeting in Toronto, Canada.

Both posters provide data on MB07811, the Company's liver-targeted, beta-subtype-selective thyroid hormone receptor (TR beta) agonist product candidate for the treatment of hyperlipidemia. The first poster provides data that show that MB07811 significantly reduced cholesterol and triglyceride levels in certain animal models with an improved therapeutic index as compared to the natural ligand, T3, or a prototype non-liver-targeted TR beta-selective agonist (KB-141). Oral administration of MB07811 to rats led to liver-selective tissue distribution with minimal effects on gene expression in extra-hepatic tissues. The studies in rats and mice showed an improved safety profile, including no cardiac effects and reduced effects on the thyroid hormone axis compared to KB-141.

The second poster provides data showing that oral administration of MB07811 resulted in a robust lowering of plasma cholesterol in a variety of animal models. Sustained efficacy was apparent with continued daily dosing for a duration of 4 to 9 weeks of treatment. Also noted, but not presented in the poster, were demonstrations of activity in a monkey model, and additive activity to statins in the monkey and rabbit models.

Thyroid hormone receptor (TR) agonists represent a novel and potentially important approach for reducing LDL-cholesterol (known as the "bad" cholesterol) and total cholesterol, liver and serum triglycerides, and lipoprotein (a) (Lp(a)). However, use of this approach has been hampered by dose-li
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Metabasis to Present at C.E. Unterberg, Towbin Emerging Growth Conference and Attend Pacific Growth Equities Conference
2. Metabasis Therapeutics to Present Poster at American Association for Cancer Research
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
5. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
6. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
7. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
8. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
9. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
10. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
11. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
Post Your Comments:
(Date:3/3/2015)... and Markets ( http://www.researchandmarkets.com/research/x5lz9r/global_poc ) has announced ... 2015-2019" report to their offering. , ... to grow at a CAGR of 8.47 percent over ... IVD devices and tools used for diagnosing diseases in ... these devices helps in the rapid diagnosis of the ...
(Date:3/3/2015)... , March 3, 2015  Michigan brothers Dominique Larkin ... called arrhythmogenic right ventricular dysplasia, or ARVD, a disease that ... sudden death among young athletes. In 2007, doctors ... basketball game. They later tested Dominique and found his "condition ... February 19, 2015 story in The Ann Arbor News ...
(Date:3/3/2015)... 2015  Web Industries, Inc., a leading provider ... Medical Device, Advanced Composites, Consumer Products, and Wire ... Medical Specialties Preferred Converter by 3M,s Medical Specialties ... to streamline their supply chains by using Web ... materials, intermediate converting services, and contract manufacturing and ...
Breaking Medicine Technology:Global POC Diagnostics Market 2015-2019 with Abbott Labs, Alere, Bayer Healthcare, Danaher, F. Hoffmann-La Roche & Johnson & Johnson Dominating 2Younger of 2 Brothers on the SynCardia Total Artificial Heart Gets a Donor Heart Transplant 2Younger of 2 Brothers on the SynCardia Total Artificial Heart Gets a Donor Heart Transplant 3Web Industries Receives 3M Preferred Converter Status 2
... VICTORIA, Australia, April 19, 2011 Genetic Technologies ... executed a preliminary research collaboration agreement to jointly develop ... world,s leading pharmaceutical companies. Under the ... property to work with this world-leading pharmaceutical company to ...
... DALLAS, April 19, 2011 GHX ... Tom Daschle addressed an audience of over 600 healthcare business ... and delivering a sustainable healthcare system at the opening keynote ... The three-day event is focused on the future of the ...
Cached Medicine Technology:GTG Announces New Product Collaboration with Global Pharmaceutical Company for Companion Diagnostics in Oncology 2Getting Healthcare Reform Done with the Entire Supply Chain 2Getting Healthcare Reform Done with the Entire Supply Chain 3Getting Healthcare Reform Done with the Entire Supply Chain 4
(Date:3/3/2015)... (PRWEB) March 04, 2015 As payers ... value-based payment contracts within the next few years, they ... the significant chunk of health care spending they control ... Inc.’s ACO Business News (ABN) tracks some of ... of a commercial accountable care organization (ACO)-type model. , ...
(Date:3/3/2015)... Calif. (PRWEB) March 03, 2015 ... provider of enterprise Time and Attendance / Workforce ... migrated to NOVAtime SaaS Workforce Management / ... time and attendance processes. , Since 2004, ... with developmental disabilities with the best quality of ...
(Date:3/3/2015)... Loma Linda, CA (PRWEB) March 03, 2015 ... its commitment to whole health and well being, it ... its vending machines across its campuses. , Over the ... nutritional leadership took part in creating dietary criteria, listening ... single vendor for the entire organization. , Most ...
(Date:3/3/2015)... Findings could lead to better therapies ... have developed and characterized a molecule that interferes with ... self-destruct. This novel mechanism was found to be effective ... type of brain cancer – and could be applicable ... to be published in the April 2015 issue of ...
(Date:3/3/2015)... 03, 2015 Dan E. Chambers, an experienced ... focus on capital crimes, recently spoke on the radio to ... The hosts of the Independent Journal Review radio show “The ... first as a prosecutor and now as a criminal defense ... made in the trial and sentencing of this high-profile case. ...
Breaking Medicine News(10 mins):Health News:AIS Newsletter Examines Ways to Engage Specialists in Value-Based Payment Contracts 2Health News:AIS Newsletter Examines Ways to Engage Specialists in Value-Based Payment Contracts 3Health News:Innovative Services, Inc. Successfully Migrates to Cloud-Based NOVAtime Workforce Management Solution to Support Growth and Improve Payroll Processing Time 2Health News:Innovative Services, Inc. Successfully Migrates to Cloud-Based NOVAtime Workforce Management Solution to Support Growth and Improve Payroll Processing Time 3Health News:Loma Linda University Health Rejuvenates Its Vending Machines with Healthier Selections 2Health News:News: UC Davis Scientists Describe Novel Drug Mechanism That Fights Brain Cancer 2Health News:News: UC Davis Scientists Describe Novel Drug Mechanism That Fights Brain Cancer 3Health News:News: UC Davis Scientists Describe Novel Drug Mechanism That Fights Brain Cancer 4Health News:Dan E. Chambers Gives Radio Interview Providing Insights into American Sniper Guilty Verdict 2Health News:Dan E. Chambers Gives Radio Interview Providing Insights into American Sniper Guilty Verdict 3
... 22 MUSCLEPHARM(R) LLC, the rising star of the ... product launch through each of Vitamin Shoppe,s 400+ locations ... this nationwide launch of our entire line of products," ... available to athletes in nearly every neighborhood across the ...
... Platform in the Bone Graft Market , , MOUNTAIN ... the bone graft market, Frost & Sullivan recognizes Bone Solutions, ... for Technology Leadership of the Year for its development of ... ligaments and tendons to bone and bone-to-bone. On May ...
... In Generics, There Is No Clear Evidence of Expanded Uptake ... from Decision Resources , , Patient-Flow Forecasts Need to ... of Therapy Over the Next Two Years , ... the world,s leading research and advisory firms focusing on pharmaceutical ...
... University Children,s Hospital Zurich has achieved a world ... patients have been successfully treated by means of ... opens new horizons for neurosurgery and the treatment ... context of a clinical study at the MR ...
... and Anthropology at the University of Haifa presented the ... conference held at the University of Haifa. , The ... silent and non-pathological expression in the everyday lives of ... past suffices for their children Aspects of ...
... Pilot program kicks off in Northwestern PA , , ... pregnant smokers about the harms of tobacco use on their ... Pennsylvania (NWPA) Tobacco Control Program are launching a new smoking ... who smoke in that region of the state. , ...
Cached Medicine News:Health News:MUSCLEPHARM Products Hit Vitamin Shoppe Shelves With a Bang! 2Health News:Frost & Sullivan Selects Bone Solutions for Technology Leadership of the Year Award 2Health News:Frost & Sullivan Selects Bone Solutions for Technology Leadership of the Year Award 3Health News:Frost & Sullivan Selects Bone Solutions for Technology Leadership of the Year Award 4Health News:Seroquel's First- and Second-Line Patient Share Has Grown Since Last Year's Analysis of Prescribing Trends in Bipolar Disorder 2Health News:Seroquel's First- and Second-Line Patient Share Has Grown Since Last Year's Analysis of Prescribing Trends in Bipolar Disorder 3Health News:Successful neurosurgery with transcranial MR-guided high-intensity focused ultrasound 2Health News:Successful neurosurgery with transcranial MR-guided high-intensity focused ultrasound 3Health News:Unspoken memories of Holocaust survivors find silent and nonpathological expression 2Health News:State Launches New Campaign to Help Pregnant Smokers Go Tobacco-Free 2
... is our most popular Low ... It offers a wide field ... and hence a slightly shorter ... be mounted to virtually and ...
This 6x or 8x aspheric magnifier is fitted with a distance piece and is particularly useful for patients with tremor or focusing difficulties. The magnifier can be either spectacle mounted or hand h...
This full segment bifocal can be screwed into a hole in a corrective or plano lens, or mounted directly on top of a prescription lens....
All Keeler magnifiers and telescope are available on a clip to fit over the patient's own spectacle...
Medicine Products: